Testing effectiveness (Phase 2)Study completedNCT01053936
What this trial is testing
Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen 129